PLoS ONE (Jan 2022)

Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.

  • Elfriede A Agyemang,
  • Andrea A Kim,
  • Trudy Dobbs,
  • Innocent Zungu,
  • Danielle Payne,
  • Andrew D Maher,
  • Kathryn Curran,
  • Evelyn Kim,
  • Hastings Kwalira,
  • Henry Limula,
  • Amitabh Adhikari,
  • Susie Welty,
  • James Kandulu,
  • Rose Nyirenda,
  • Andrew F Auld,
  • George W Rutherford,
  • Bharat S Parekh

DOI
https://doi.org/10.1371/journal.pone.0262071
Journal volume & issue
Vol. 17, no. 2
p. e0262071

Abstract

Read online

Tests for recent HIV infection (TRI) distinguish recent from long-term HIV infections using markers of antibody maturation. The limiting antigen avidity enzyme immunoassay (LAg EIA) is widely used with HIV viral load (VL) in a recent infection testing algorithm (RITA) to improve classification of recent infection status, estimate population-level HIV incidence, and monitor trends in HIV transmission. A novel rapid test for recent HIV infection (RTRI), Asanté™, can determine HIV serostatus and HIV recency within minutes on a lateral flow device through visual assessment of test strip or reader device. We conducted a field-based laboratory evaluation of the RTRI among pregnant adolescent girls and young women (AGYW) attending antenatal clinics (ANC) in Malawi.We enrolled pregnant AGYW aged 90% and >0.65 respectively indicating substantial agreement between the RITAs.This was the first field evaluation of an RTRI in sub-Saharan Africa, which demonstrated good performance of the assay and feasibility of integrating RTRI into routine HIV testing services for real-time surveillance of recent HIV infection.